Clinical characteristics, treatment, and treatment switch after molecular‐genetic classification in individuals with maturity‐onset diabetes of the young: Insights from the multicenter real‐world DPV registry.

MLA

Lanzinger, Stefanie, et al. “Clinical Characteristics, Treatment, and Treatment Switch after Molecular‐genetic Classification in Individuals with Maturity‐onset Diabetes of the Young: Insights from the Multicenter Real‐world DPV Registry.” Journal of Diabetes, vol. 16, no. 11, Nov. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1111/1753-0407.70028.

APA

Lanzinger, S., Laubner, K., Warncke, K., Mader, J. K., Kummer, S., Boettcher, C., Biester, T., Galler, A., Klose, D., & Holl, R. W. (2024). Clinical characteristics, treatment, and treatment switch after molecular‐genetic classification in individuals with maturity‐onset diabetes of the young: Insights from the multicenter real‐world DPV registry. Journal of Diabetes, 16(11), 1–13. https://doi.org/10.1111/1753-0407.70028

Chicago

Lanzinger, Stefanie, Katharina Laubner, Katharina Warncke, Julia K. Mader, Sebastian Kummer, Claudia Boettcher, Torben Biester, Angela Galler, Daniela Klose, and Reinhard W. Holl. 2024. “Clinical Characteristics, Treatment, and Treatment Switch after Molecular‐genetic Classification in Individuals with Maturity‐onset Diabetes of the Young: Insights from the Multicenter Real‐world DPV Registry.” Journal of Diabetes 16 (11): 1–13. doi:10.1111/1753-0407.70028.